Wed Sep 4, 2013 3:25pm EDT
(Reuters) – A high-stakes decision on whether to extend U.S. marketing exclusivity of Eli Lilly and Co’s blockbuster Alimta lung cancer drug is not expected until next year, following a two-week trial in Indianapolis federal…
Patent ruling on Lilly’s Alimta lung-cancer drug expected in 2014
No comments:
Post a Comment